Salmon Calcitonin is currently administered by injection for the treatment of osteoporosis in postmenopausal women. An oral dosage form is not available due to its poor oral bioavailability. Scientists have applied technologies to overcome duodenal and sublingual biological barriers.

Everything remains in the animal PK phase and this shows that the macromolecule has great potential for oral delivery.